HPV associated oropharyngeal tumor incidence.

Recruiting

• Conditions: C01; C02.0; C02.4; C02.8; C09.0; C02.9; C05.1; C05.2; C05.8; C05.9

• Registration Number: DRKS00028010
• Lead Sponsor: niversitätsmedizin Göttingen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients with newly diagnosed oropharyngeal tumors are included. The collection and analysis of the data is done according to DSGVO. Both HPV-positive oropharyngeal tumors as well as HPV-negative oropharyngeal tumors are included.

Exclusion Criteria

None

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
An epidemiologic survey of HPV-associated oropharyngeal tumors and the impact of HPV vaccination on the incidence of HPV-associated oropharyngeal tumors.

Secondary Outcome Measures

Name	Time	Method
Impact of HPV vaccination on the incidence of HPV-associated oropharyngeal tumors.